Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.

Bednarski, Brian K; Araujo, Dejka M; Yi, Min; Torres, Keila E; Lazar, Alexander; Trent, Jonathan C; Cormier, Janice N; Pisters, Peter W T; Lev, Dina Chelouche; Pollock, Raphael E; Feig, Barry W; Hunt, Kelly K

Bednarski, Brian K; Araujo, Dejka M; Yi, Min; Torres, Keila E; Lazar, Alexander; Trent, Jonathan C; Cormier, Janice N; Pisters, Peter W T; Lev, Dina Chelouche; Pollock, Raphael E; Feig, Barry W; Hunt, Kelly K.

Affiliation

Bednarski BK; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ann Surg Oncol ; 21(8): 2499-505, 2014 Aug.

Article in En | MEDLINE | ID: mdl-24639192

Subject(s)

Gastrointestinal Stromal Tumors/drug therapy; Neoplasm Recurrence, Local/drug therapy; Protein Kinase Inhibitors/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors/mortality; Gastrointestinal Stromal Tumors/pathology; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local/mortality; Neoplasm Recurrence, Local/pathology; Neoplasm Staging; Prognosis; Survival Rate

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Gastrointestinal Stromal Tumors / Protein Kinase Inhibitors / Neoplasm Recurrence, Local Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google